Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 4, 1996, Pages 1488-1494

  Tuomi, Tiinamaija ^a   Björses, Petra ^b,c   Falorni, Alberto ^g   Partanen, Jukka ^d   Perheentupa, Jaakko ^e   Lernmark, Åke ^h   Miettinen, Aaro ^f  

^a LUND UNIVERSITY   (Sweden)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d Tissue Typing Laboratory   (Finland)

^e UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^f UNIVERSITY OF HELSINKI   (Finland)

^g KAROLINSKA INSTITUTE   (Sweden)

^h UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUTAMATE DECARBOXYLASE; HLA ANTIGEN; INSULIN; MONOCLONAL ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSIS; ENZYME ISOLATION; FEMALE; GENETIC RISK; GENOTYPE; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MALE; MULTIPLE ENDOCRINE ADENOMATOSIS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AUTOANTIBODIES; C-PEPTIDE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; GENES, MHC CLASS II; GENOTYPE; GLUTAMATE DECARBOXYLASE; HISTOCOMPATIBILITY TESTING; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; INFANT; INSULIN; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; POLYENDOCRINOPATHIES, AUTOIMMUNE; POLYMERASE CHAIN REACTION;

EID: 0029988330     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.4.1488     Document Type: Article

References (48)

1. Davies JL, Kawaguchi Y, Bennett ST, et al. 1994 A genome-wide search for human type 1 diabetes susceptibility genes. Nature. 371:130-136.
2. Baekkeskov S, Aanstoot H, Christgau S, et al. 1990 Identification of the 64K autoantigen in insulin-dependent diabetes mellitus as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature. 347:151-156.
3. Greenbaum CJ, Brooks-Worrell BM, Palmer JP, Lernmark Å. 1994 Autoimmunity and prediction of insulin dependent diabetes mellitus. In: Marshall SM, Home PD, eds. The diabetes annual. Amsterdam: Elsevier; vol 8:21-52.
4. Atkinson MA, Kaufman DL, Campbell L, et al. 1992 Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet. 339:458-459.
5. Kaufman DL, Clare-Salzler M, Tian J, et al. 1993 Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature. 366:69-71.
6. Tisch R, Yang X, Singer SM, Liblau RS, Fugger L, McDewitt HO. 1993 Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature. 366:72-75.
7. Bosi E, Becker F, Bonifacio E, et al. 1991 Progression to type 1 diabetes in autoimmune endocrine patients with islet cell antibodies. Diabetes. 40:977-984.
8. Ahonen P, Miettinen A, Perheentupa J. 1985 Cytoplasmic islet cell antibodies in patients with autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy (APECED) [Abstract]. Acta Endocrinol (Copenh). 109(Suppl 270): 78.
9. Solimena M, Folli F, Aparisi R, Pozza G, De Camilli P. 1990 Autoantibodies to GABA-ergic neurons and pancreatic beta cells in Stiff-Man syndrome. N Engl J Med. 322:1555-1560.
10. Falorni A, Kockum I, Sanjeevi CB, Lernmark Å. 1995 Pathogenesis of insulin-dependent diabetes mellitus. Clin Endocrinol Metab. 9:25-46.
11. Wheelman AP. 1995 Autoimmunity to steroid-producing cells and familial polyendocrine autoimmunity. Clin Endocrinol Metab. 9:157-174.
12. Ahonen P, Myllärniemi S, Sipilä I, Perheentupa J. 1990 Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med. 322:1829-1836.
13. Aaltonen J, Björses P, Sandkijl L, Perheentupa J, Peltonen L. 1994 An autosomal locus causing autoimmune disease: autoimmune polyglandular disease type I assigned to chromosome 21. Nature Genet. 8:83-88.
14. Grubin E, Daniels T, Toivola B, et al. 1994 A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia. 37:344-350.
15. 3H recombinant human ligands. J Immunol Methods. In press.
16. Karlsen AE, Hagopian WA, Grubin CE, et al. 1991 Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10. Proc Natl Acad Sci USA. 88:8337-8841.
17. Michelsen B, Petersen JS, Boel E, Møldrup A, Dyrberg T, Madsen OD. 1991 Cloning, characterization and autoimmune recognition of rat islet glutamic acid decarboxylase in insulin-dependent diabetes mellitus (IDDM). Proc Natl Acad Sci USA. 88:8754-8758.
18. Li L, Jiang J, Hagopian WA, et al. 1995 Differential detection of rat islet and brain glutamic acid decarboxylase (GAD) isoforms with sequence-specific peptide antibodies. J Histochem Cytochem. 43:53-59.
19. Schmidli RS, Colman P, Bonifacio E, Bottazzo GF, Harrison LC. 1994 High level of concordance between assays for glutamic acid decarboxylase antibodies. First International Glutamic Acid Decarboxylase Antibody Workshop. Diabetes. 43:1005-1009.
20. Falorni A, Grubin CE, Takei I, et al. 1994 Radioimmunoassay detects the frequent occurrence of autoantibodies to the Mr 65,000 isoform of glutamic acid decarboxylase in Japanese insulin-dependent diabetes. Autoimmunity. 19: 113-125.
21. Miettinen A, Holthöfer H, Kontiainen S, Miettinen M, Andersson LC. 1989 Antibodies against gastrointestinal carcinoid tumors in IDDM. Diabetes. 38: 667-669.
22. Ota M, Seki T, Nomura N, et al. 1991 Modified PCR-RFLP method for HLA-DPB1 and -DQA1 genotyping. Tissue Antigens. 38:60-71.
23. Kimura A, Sasazuki T. 1992 Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique. In: Sasazuki T, ed. HLA 1991. Oxford: Oxford University Press; vol 1:397-425.
24. Westman P, Kuismin T, Partanen J, Koskimies S. 1993 An HLA-DR typing protocol using group-specific PCR-amplification followed by restriction enzyme digests. Eur J Immunogen. 20:103-109.
25. National Diabetes Data Group. 1979 Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 28:1039-1057.
26. Grimaldi LME, Martino G, Braghi S, et al. 1993 Heterogeneity of autoantibodies in stiff-man syndrome. Ann Neurol. 34:57-64.
27. Hallengren B, Falorni A, Landin-Olsson M, Lernmark Å, Papadopoulos K, Sundqvist G. 1995 Islet cell and glutamic acid decarboxylase antibodies in hyperthyroid patients-at diagnosis and following treatment. J Intern Med. In press.
28. Seissler J, Bieg S, Yassin N, et al. 1995 Association between antibodies to the MR 67,000 isoform of glutamate decarboxylase (GAD) and type 1 (insulin-dependent) diabetes mellitus with coexisting autoimmune polyendocrine syndrome type II. Autoimmunity. In press.
29. Velloso A, Winqvist O, Gustafsson J, Kämpe O, Karlsson FA. 1994 Autoantibodies against a novel 52-KDa islet antigen and glutamate decarboxylase isoforms in autoimmune polyendocrine syndrome type 1. Diabetologia. 37: 61-69.
30. Bonifacio EP, Bingley PJ, Shattock M, et al. 1990 Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet. 335:147-149.
31. Riley WJ, MacLaren NK, Krischer J, et al. 1990 A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med. 323:1167-1172.
32. Schott M, Schatz D, Atkinson M, et al. 1994 GAD65 Autoantibodies increase the predictability but not the sensitivity of islet cell and insulin autoantibodies for developing insulin dependent diabetes mellitus. J Autoimmun. 7:865-872.
33. Schmidli RS, Colman PG, Harrison LC. 1994 Do glutamic acid decarboxylase antibodies improve the prediction of IDDM in first-degree relatives at risk for IDDM?. J Autoimmun. 7:873-879.
34. Elliott RB, Pilcher CC. 1994 A universal model of antibody prediction (MAP) of type 1 diabetes in children. J Autoimmun. 7:881-888.
35. Bruining GJ, Grobbee DE, Scheffer GJ, et al. 1989 Ten-year follow-up study of islet-cell antibodies diabetes mellitus. Lancet. 1:1100-1103.
36. Aanstoot H-J, Sigurdsson E, Jaffe M, et al. 1994 Value of antibodies to GAD65 combined with islet cell cytoplasmic antibodies for predicting IDDM in a childhood population. Diabetologia. 37:917-924.
37. Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles WJ, Mackay IR. 1993 Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin dependent onset of disease. Diabetes. 42:359-362.
38. Hagopian WA, Karlsen AE, Gottsäter A, et al. 1993 Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD-64) showed 64K autoantibody positivity at onset predicts diabetes type. J Clin Invest. 91:368-374.
39. Betterle C, Presotto F, Pedini B, et al. 1987 Islet cell and insulin autoantibodies in organ-specific autoimmune patients. Their behaviour and predictive value for the development of type 1 (insulin-dependent) diabetes mellitus. A 10-year follow-up study. Diabetologia. 30:292-297.
40. Björk E, Velloso LA, Kämpe O, Karlson FA. 1993 GAD autoantibodies in IDDM, stiff-man syndrome and autoimmune polyendocrine syndrome type 1 recognize different epitopes. Diabetes. 43:161-165.
41. Tuomi T, Rowley MJ, Knowles WJ, et al. 1994 Autoantigenic properties of native and denatured glutamic acid decarboxylase: evidence for a conformational epitope. Clin Immunol Immunopathol. 71:53-59.
42. Winqvist O, Gustafsson J, Rorsman F, Karlsson FA, Kämpe O. 1993 Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison's disease. J Clin Invest. 92:2377-2385.
43. Uibo R, Aaik E, Peterson P, et al. 1994 Autoantibodies to cytochrome P450 enzymes P450scc, P450c17, and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison's disease. J Clin Endocrinol Metab. 78:323-328.
44. Ahonen P, Miettinen A, Perheentupa J. 1987 Adrenal and steroidal cell antibodies in patients with autoimmune polyglandular disease type I (APG type I) and risk of adrenocortical ovarian failure. J Clin Endocrinol Metab. 64:494-500.
45. Wagner R, McNally JM, Bonifazio E, et al. 1994 Lack of immunohistochemical changes in the islets of nondiabetic, autoimmune, polyendocrine patients with β-selective GAD-specific islet cell antibodies. Diabetes. 43:851-856.
46. Partanen J, Peterson P, Westman P, Aranko S, Krohn K. 1994 Major histocompatibility complex class II and III in Addison's disease. MHC alleles do not predict autoantibody specificity and 21-hydroxylase gene polymorphism has no independent role in disease susceptibility. Hum Immunol. 41:135-140.
47. Brooks EG, Klimpel GR, Vaidya S, et al. 1994 Thymic hypoplasia and T-cell deficiency in ectodermal dysplasia: case report and review of the literature. Clin Immunol Immunopathol. 71:44-52.
48. Thomson G, Robinson WP, Kuhner MK, et al. 1988 Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus. Am J Hum Genet. 43:799-816.